Intravenous immune globulin is a therapeutic preparation ofnormal human polyclonal IgG obtained from plasma pooled fromseveral thousand healthy blood donors. Initially used in treatingprimary and secondary immune deficiencies, intravenous immuneglobulin is increasingly used for the treatment of diverse autoimmuneand systemic inflammatory diseases including immune thrombocytopenia,Guillain–Barré syndrome, chronic inflammatory demyelinatingpolyneuropathy, myasthenia gravis, dermatomyositis, and Kawasaki'ssyndrome.
Several non–mutually exclusive mechanisms have been proposedto explain the beneficial effects of intravenous immune globulinin patients.1 One such process was proposed by Ravetch et al.in 20062: that the beneficial effect of intravenous immune globulin. . . [Full Text of this Article]
Source Information
From the Institut National de la Santé et de la Recherche Médicale, Université Pierre et Marie Curie, Université Paris Descartes, Centre de Recherche des Cordeliers, Paris.
This article has been cited by other articles:
Mayadas, T. N., Tsokos, G. C., Tsuboi, N.
(2009). Mechanisms of Immune Complex-Mediated Neutrophil Recruitment and Tissue Injury. Circulation
120: 2012-2024
[Full Text]
Zandman-Goddard, G, Blank, M, Shoenfeld, Y
(2009). Intravenous immunoglobulins in systemic lupus erythematosus: from the bench to the bedside. Lupus
18: 884-888
[Abstract]
Fourtounas, C., Mouzaki, A., Vlachojannis, J. G., Jordan, S. C., Vo, A. A., Reinsmoen, N. L.
(2008). Desensitization during Renal Transplantation. NEJM
359: 1731-1732
[Full Text]